- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3185EUR$3,500USD£2,731GBP
- Report
- December 2021
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
The Giardia Diagnostic market is a subset of the larger Diagnostics industry. It is focused on the detection and diagnosis of Giardia, a parasitic infection that affects the digestive system. Diagnostic tests for Giardia are used to identify the presence of the parasite in a patient's body, and to determine the severity of the infection. Diagnostic tests for Giardia can be performed using a variety of methods, including microscopy, enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction (PCR).
Giardia Diagnostic tests are used in both clinical and research settings, and are important for the diagnosis and treatment of Giardia infections. They are also used to monitor the effectiveness of treatment and to prevent the spread of the infection.
Some companies in the Giardia Diagnostic market include Bio-Rad Laboratories, DiaSorin, GenMark Diagnostics, and Luminex Corporation. Show Less Read more